Type 2 diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group: using 1 serving dried jujube=28g dried jujube daily for 3 months. Intervention 2: Control group: no consumption of any forms of jujube during study (3 months).
Treatment - Other
Intervention group: using 1 serving dried jujube=28g dried jujube daily for 3 months.
Control group: no consumption of any forms of jujube during study (3 months)
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: inclusion criteria:diabetic patients aged between 20-65 years; FBS more than or equal to 126 mg/dl and less than 200 mg/dl; glycosylated hemoglobin 6.5-9 percent; lack of insulin consumption; lack of history of metabolic diseases,cardiovascular disease,renal disease,tyroid ,cancer; willingness to cooperation; lack of pregnancy and lactation; no consumption of alcoholic beverages; lack of smoking; no consumption of any drug that are metabolized in P450 cytochrome. exclusion criteria:lack of willingness to continue study; Occurrence infectious disease during studys; Occurrence pregnancy during study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FBS. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Enzymatic method.;HbA1C. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Bronnate Affinity.;Insulin. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Radio Immuno Assay(RIA).;Insulin Sensitivity. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Quantitative insulin sensitivity check index ;QUICKI.;Insulin Resistance. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Homeostasis model assessment ; HOMA.;TG. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Enzymatic method.;Total chol. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Enzymatic method.;LDL-C. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Enzymatic method.;HDL-C. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Enzymatic method.;ApoA1. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Immunoturbidimetry method.;ApoB100. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Immunoturbidimetry method.;ALT. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Enzymatic method.;AST. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Enzymatic method.;Hs-CRP. Timepoint: Before intervention and 3 months after intervention. Method of measurement: ELISA test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dietary intake. Timepoint: Before intervention and 3 months after intervention. Method of measurement: 24-hour recall questinnaire.;Blood Pressure. Timepoint: Before intervention and 3 months after intervention. Method of measurement: digital Barometer.;Physical Activity. Timepoint: Before intervention and 3 months after intervention. Method of measurement: international physical activity questionarre.;Weight. Timepoint: Before intervention and 3 months after intervention. Method of measurement: digital scale.;BMI. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Weight(kg)/(height(m))2. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarzad Shidfar
Iran University of Medical Sciences
Outcome results
None listed